MNK - Oppenheimer likes Incyte in premarket analyst action September, 05 2019 07:49 AM Mallinckrodt plc Orchard Therapeutics (NASDAQ:ORTX) initiated with Overweight rating at Barclays.More news on: Orchard Therapeutics plc, Idera Pharmaceuticals, Inc., Incyte Corporation, Healthcare stocks news, Stocks on the move, , Read more ...